Back to dashboard
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 17 September 2026 | Benjamin (Ben) HohlCFO | Sell Option/Award related | 3,535 | $50.03 | $176,851.10 | 40,483 |
| 17 September 2026 | Benjamin (Ben) HohlCFO | Sell Regular sell transaction (market) | 2,194 | $50.72 | $111,270.47 | 38,289 |
| 17 September 2026 | Benjamin (Ben) HohlCFO | Sell Option/Award related | 289 | $51.49 | $14,881.45 | 38,000 |
| 17 September 2026 | Helen Louise CollinsOther Level A | Sell Option/Award related | 2,916 | $50.03 | $145,890.98 | 27,084 |
| 17 September 2026 | Helen Louise CollinsOther Level A | Sell Option/Award related | 1,844 | $50.71 | $93,507.21 | 25,240 |
| 17 September 2026 | Helen Louise CollinsOther Level A | Sell Option/Award related | 240 | $51.48 | $12,355.68 | 25,000 |
| 17 August 2026 | Benjamin (Ben) HohlCFO | Sell Regular sell transaction (market) | 4,630 | $58.35 | $270,168.37 | 41,424 |
| 17 August 2026 | Benjamin (Ben) HohlCFO | Sell Regular sell transaction (market) | 1,388 | $59.35 | $82,382.80 | 40,036 |
| 17 August 2026 | Helen Louise CollinsOther Level A | Sell Option/Award related | 3,900 | $58.37 | $227,649.63 | 26,100 |
| 17 August 2026 | Helen Louise CollinsOther Level A | Sell Option/Award related | 1,100 | $59.35 | $65,281.15 | 25,000 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 22 June 2026 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 787,024 | $45.38 | $35,715,149.12 | 6,601,878 |
| 15 June 2026 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 272,322 | $45.02 | $12,259,936.44 | 7,388,902 |
| 4 August 2026 | Mika Kakefuda DerynckIndependent Director | Sell Option/Award related | 158,795 | $60.21 | $9,561,586.85 | 0 |
| 22 June 2026 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 46,776 | $45.00 | $2,104,920.00 | 6,555,102 |
| 9 January 2026 | Joseph P (Joe) LyssikatosPresident | Sell Regular sell transaction (market) | 50,000 | $29.13 | $1,456,715.00 | 765,188 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.